Vinexin contributes to autophagic decline in brain ageing across species.
Authors
Park, So Jung
Karabiyik, Cansu
Son, Sung Min
Siddiqi, Farah H
Bento, Carla F
Sterk, Peter
Vicinanza, Mariella
Publication Date
2022-05Journal Title
Cell Death Differ
ISSN
1350-9047
Publisher
Springer Science and Business Media LLC
Volume
29
Issue
5
Pages
1055-1070
Language
en
Type
Article
This Version
VoR
Metadata
Show full item recordCitation
Park, S. J., Frake, R. A., Karabiyik, C., Son, S. M., Siddiqi, F. H., Bento, C. F., Sterk, P., et al. (2022). Vinexin contributes to autophagic decline in brain ageing across species.. Cell Death Differ, 29 (5), 1055-1070. https://doi.org/10.1038/s41418-021-00903-y
Description
Funder: Sims Fund Frank Edward Elmore Fund
Funder: Romanian grant from ministry of Research and Innovation
Funder: EC | EC Seventh Framework Programm | FP7 Health (FP7-HEALTH - Specific Programme "Cooperation": Health); doi: https://doi.org/10.13039/100011272; Grant(s): 2012-305121
Funder: UK Dementia Research Institute
Abstract
Autophagic decline is considered a hallmark of ageing. The activity of this intracytoplasmic degradation pathway decreases with age in many tissues and autophagy induction ameliorates ageing in many organisms, including mice. Autophagy is a critical protective pathway in neurons and ageing is the primary risk factor for common neurodegenerative diseases. Here, we describe that autophagosome biogenesis declines with age in mouse brains and that this correlates with increased expression of the SORBS3 gene (encoding vinexin) in older mouse and human brain tissue. We characterise vinexin as a negative regulator of autophagy. SORBS3 knockdown increases F-actin structures, which compete with YAP/TAZ for binding to their negative regulators, angiomotins, in the cytosol. This promotes YAP/TAZ translocation into the nucleus, thereby increasing YAP/TAZ transcriptional activity and autophagy. Our data therefore suggest brain autophagy decreases with age in mammals and that this is likely, in part, mediated by increasing levels of vinexin.
Keywords
Article, /631/80/39/2346, /631/378/2611, /13, /13/89, /13/44, /13/95, /14, /14/19, /38, /38/89, /38/91, article
Sponsorship
Funding for this study was obtained from the UK Dementia Research Institute (funded by the MRC, Alzheimer’s Research UK and the Alzheimer’s Society), the Roger de Spoelberch Foundation, the Cambridge Centre for Parkinson-Plus, the Wellcome Trust [095317/Z/11/Z and 100140/Z/12/Z] and the NEUROMICS project (European Community’s Seventh Framework Programme under grant agreement number 2012-305121). In addition, R.A.F. received funding through the University of Cambridge MB/PhD Programme (Sims Scholarship, James Baird Fund and the Frank Edward Elmore Fund), C.K. received funding from a Gates Cambridge Scholarship and M.P. received a grant of the Romanian Ministry of Research, Innovation and Digitization, CNCS/CCCDI-UEFISCDI, project number PN-III-P1-1.1-PD-2019-0733, within PNCDI-III and POC/448/1/1/127606 CENEMED project.
Funder references
Wellcome Trust (095317/Z/11/Z)
Wellcome Trust (100140/Z/12/Z)
European Commission (305121)
Identifiers
s41418-021-00903-y, 903
External DOI: https://doi.org/10.1038/s41418-021-00903-y
This record's URL: https://www.repository.cam.ac.uk/handle/1810/336985
Rights
Licence:
http://creativecommons.org/licenses/by/4.0/
Statistics
Total file downloads (since January 2020). For more information on metrics see the
IRUS guide.
Recommended or similar items
The current recommendation prototype on the Apollo Repository will be turned off on 03 February 2023. Although the pilot has been fruitful for both parties, the service provider IKVA is focusing on horizon scanning products and so the recommender service can no longer be supported. We recognise the importance of recommender services in supporting research discovery and are evaluating offerings from other service providers. If you would like to offer feedback on this decision please contact us on: support@repository.cam.ac.uk